Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6FS7

Influenza A/California/04/2009 (pH1N1) endonuclease with I38T mutation with bound inhibitor, baloxavir acid (BXA)

6FS7 の概要
エントリーDOI10.2210/pdb6fs7/pdb
分子名称Polymerase acidic protein,Polymerase acidic protein, MANGANESE (II) ION, Baloxavir acid, ... (4 entities in total)
機能のキーワードinfluenza, endonuclease, inhibitor, viral protein
由来する生物種Influenza A virus (A/California/04/2009(H1N1))
詳細
タンパク質・核酸の鎖数6
化学式量合計138642.16
構造登録者
Cusack, S.,Speranzini, V. (登録日: 2018-02-19, 公開日: 2018-07-11, 最終更新日: 2024-01-17)
主引用文献Omoto, S.,Speranzini, V.,Hashimoto, T.,Noshi, T.,Yamaguchi, H.,Kawai, M.,Kawaguchi, K.,Uehara, T.,Shishido, T.,Naito, A.,Cusack, S.
Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil.
Sci Rep, 8:9633-9633, 2018
Cited by
PubMed Abstract: Baloxavir acid (BXA), derived from the prodrug baloxavir marboxil (BXM), potently and selectively inhibits the cap-dependent endonuclease within the polymerase PA subunit of influenza A and B viruses. In clinical trials, single doses of BXM profoundly decrease viral titers as well as alleviating influenza symptoms. Here, we characterize the impact on BXA susceptibility and replicative capacity of variant viruses detected in the post-treatment monitoring of the clinical studies. We find that the PA I38T substitution is a major pathway for reduced susceptibility to BXA, with 30- to 50-fold and 7-fold EC changes in A and B viruses, respectively. The viruses harboring the I38T substitution show severely impaired replicative fitness in cells, and correspondingly reduced endonuclease activity in vitro. Co-crystal structures of wild-type and I38T influenza A and B endonucleases bound to BXA show that the mutation reduces van der Waals contacts with the inhibitor. A reduced affinity to the I38T mutant is supported by the lower stability of the BXA-bound endonuclease. These mechanistic insights provide markers for future surveillance of treated populations.
PubMed: 29941893
DOI: 10.1038/s41598-018-27890-4
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.96 Å)
構造検証レポート
Validation report summary of 6fs7
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon